Tirtha Chakraborty Vor Biopharma Inc. (VOR) insider trading activity

Tirtha Chakraborty is CHIEF SCIENTIFIC OFFICER of Vor Biopharma Inc.. Currently has a direct ownership of 220,239 shares of VOR, which is worth approximately $301,727. The most recent transaction as insider was on Feb 06, 2025, when has been sold 1,033 shares (Common Stock) at a price of $1.5 per share, resulting in proceeds of $1,549. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 220K

29.6% 3M change

17.98% 12M change

Total Value Held $301,727

Tirtha Chakraborty Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 06 2025	SELL Payment of exercise price or tax liability	$1,549 $1.5 p/Share	1,033 Reduced 0.47%	220,239 Common Stock
Feb 03 2025	SELL Payment of exercise price or tax liability	$1,558 $1.34 p/Share	1,163 Reduced 0.68%	168,772 Common Stock
Feb 03 2025	BUY Grant, award, or other acquisition	-	52,500 Added 19.18%	221,272 Common Stock
Nov 06 2024	SELL Payment of exercise price or tax liability	$752 $0.86 p/Share	875 Reduced 0.51%	169,935 Common Stock
Nov 01 2024	SELL Payment of exercise price or tax liability	$788 $0.8 p/Share	986 Reduced 0.57%	170,810 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$4,628 $0.83 p/Share	5,576 Reduced 3.14%	171,796 Common Stock
Aug 06 2024	SELL Payment of exercise price or tax liability	$762 $0.87 p/Share	876 Reduced 0.49%	177,372 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$925 $0.94 p/Share	985 Reduced 0.55%	178,248 Common Stock
May 06 2024	SELL Payment of exercise price or tax liability	$1,531 $1.75 p/Share	875 Reduced 0.49%	179,233 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$1,743 $1.77 p/Share	985 Reduced 0.54%	180,108 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$12,657 $2.27 p/Share	5,576 Reduced 2.99%	181,093 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	$2,396 $2.32 p/Share	1,033 Reduced 0.55%	186,669 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	53,750 Added 22.26%	187,702 Common Stock
Nov 06 2023	SELL Payment of exercise price or tax liability	$1,594 $1.82 p/Share	876 Reduced 0.65%	133,952 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$14,887 $2.67 p/Share	5,576 Reduced 3.97%	134,828 Common Stock
Aug 07 2023	SELL Payment of exercise price or tax liability	$2,336 $2.67 p/Share	875 Reduced 0.62%	140,404 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$3,622 $4.14 p/Share	875 Reduced 0.62%	141,279 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$30,723 $5.51 p/Share	5,576 Reduced 3.77%	142,154 Common Stock
Feb 06 2023	BUY Grant, award, or other acquisition	-	47,750 Added 24.43%	147,730 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	-	76,000 Added 43.94%	96,980 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	$23,727 $1.36 p/Share	17,446 Added 45.4%	20,980 Common Stock
Feb 09 2021	BUY Conversion of derivative security	-	3,534 Added 50.0%	3,534 Common Stock

Tirtha Chakraborty

CHIEF SCIENTIFIC OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VOR shares.

Notify only if

Value

Insider Trading

Get notified when an Vor Biopharma Inc. insider buys or sells VOR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vor Biopharma Inc.

Track Activities on VOR

Account